Studying the interactions of schistosome EVs with host CLRs not only increases our understanding of the roles of CLRs during helminth infections, it can also tell us how we could target these CLRs to either generate immune activation to fight infections and tumors or to induce immunotolerance to dampen unwanted inflammations. The gene discussed is LARS1; the disease is helminthiasis.